Faculty

Institution

Unit

Venue

Frank L. Meyskens

Professor

University of California, Irvine

Affiliations

School of Medicine

Biological Chemistry

Frank L. Meyskens is currently serving as a Biological Chemistry Professor at University of California, Irvine.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Frank L. Meyskens

University of California, Irvine

Professor

You can click a keyword to filter the displayed items

oncology cancer research pharmacology dermatology tumor biology medicine melanoma health sciences cancer biology cancer prevention medicinal research skin cancer cancer care cancer treatment clinical research clinical trials cancer immunotherapy cancer cells leukemia molecular cancer pharmacotherapy cancer management cancer genetics cancer risk preventive medicine anti-cancer agents tumor targeting colorectal cancer prostate cancer carcinogenesis mammalian biology chemoprevention strategies redox biology cancer genomics oncogenes gynecologic oncology experimental medicine vascular biology cutaneous biology biomedical research cellular physiology clinical evidence human melanoma cancer imaging drug development health prevention melanoma cells medical nutrition human melanoma cells respiratory medicine treatment and prevention clinical medicine epidemiology of cancer clinical dermatology soft agar nutritional sciences cancer growth therapeutic efficacy hematological malignancies cell growth cell regulation clinical pharmacology metastatic melanoma human melanocytes genitourinary cancers apoptosis human cancer prostate cancer risk cancer patients phase iia trial malignant melanoma phase ii study phase ii trial skin cancer chemoprevention efficacy trial intraepithelial neoplasia

Notable Scholarly Works

Notable Federal Grants

Collaborators

Data From Back to the Future: Mechanism-Based, Mutation-Specific Combination Chemoprevention With a Synthetic Lethality Approach. (2023)

Frank L. MeyskensEugene W. Gerner

pharmacologymutation-specific combination chemopreventiongeneticsmedicinal chemistry

Data From Regulatory Approval of Cancer Risk-Reducing (Chemopreventive) Drugs: Moving What We Have Learned Into the Clinic. (2023)

Frank L. MeyskensGregory A. CurtDean E. BrennerGary GordonRonald B. HerbermanOlivera FinnGary J. KelloffSamir N. KhleifCaroline C. SigmanEva Szabo

medicinepharmacologycancer risk-reducingresearch policydrug policyoncologycancer riskcancer preventionhealth policy

Data From Topically Applied Carvedilol Attenuates Solar Ultraviolet Radiation Induced Skin Carcinogenesis. (2023)

Kevin M. HuangSherry LiangSteven YeungEtuajie OiyemhonlanKristan H. ClevelandCyrus ParsaRobert OrlandoFrank L. MeyskensBradley T. AndresenYing Huang

carcinogenesisdermatologyradiation oncologyskin carcinogenesiscutaneous biologyskin cancersolar ultraviolet radiation

Recent Advances in Clinical Research for Skin Cancer Chemoprevention. Cancers (2023)

Ruby TowSamuel HanounBradley AndresenAyaz ShahidJeffrey WangKristen M. KellyFrank L. MeyskensYing Huang

dermatologycancer careradiation oncologyepidemiologycancer researchclinical researchoncologyskin cancer chemopreventioncancer treatmentskin cancercancer prevention

Supplementary Figure Legends From Topically Applied Carvedilol Attenuates Solar Ultraviolet Radiation Induced Skin Carcinogenesis. (2023)

Kevin M. HuangSherry LiangSteven YeungEtuajie OiyemhonlanKristan H. ClevelandCyrus ParsaRobert OrlandoFrank L. MeyskensBradley T. AndresenYing Huang

carcinogenesisdermatologyradiation oncologyradiation biologyoral cancerskin carcinogenesisskin cancercutaneous biologypathologytumor biologysolar ultraviolet radiation

Transfersome Encapsulated With the R-Carvedilol Enantiomer for Skin Cancer Chemoprevention. Nanomaterials (2023)

Md Abdullah ShamimAyaz ShahidPabitra K. SardarSteven YeungJeremiah ReyesJenny KimCyrus ParsaRobert OrlandoJeffrey WangKristen M. KellyFrank L. MeyskensBradley T. AndresenYing Huang

nanobiotechnologymaterials sciencedermatologynanomedicinebiomedical engineeringskin cancer chemopreventionnanomaterialstherapeutic nanomaterialsr-carvedilol enantiomerdrug deliverynanotechnology

Replace the Advance Directive With a Patient Activation Approach to Serious Illness Communication. Journal of the American Geriatrics Society (2022)

Mark Allen O'RourkeJamie S. MyersFrank L. Meyskens

advance directivehealth communicationcritical caregeriatric medicinegeriatricsserious illness communication

Miracles. Encyclopedia of the Bible Online (2021)

David BarrattGeorge D. ChryssidesMitchell HamiltonBernd KollmannErkki KoskenniemiSara KuehnAri LammEphraim MeirNils Holger PetersenMartin PrudkýRobin RinehartTheresa SandersDov SchwartzOri Z. SoltesJanet E. SpittlerDavid WeddleGiselle de Nie

The Ionophore Thiomaltol Induces Rapid Lysosomal Accumulation of Copper and Apoptosis in Melanoma. Metallomics (2021)

Ottis ScrivnerLong DaoM Karen Newell-RogersBabbak ShahandehFrank L MeyskensSusan Kurumi KozawaFeng Liu-SmithGermán Plascencia-VillaMiguel José-YacamánShang JiaChristopher J ChangPatrick J Farmer

materials sciencedermatologycell deathmelanomacancer researchapplied microbiologyredox biologymetal toxicityapoptosisbiological inorganic chemistryoncologylysosomal accumulationinorganic chemistryskin cancertumor biologymetalstransition metal chemistrycell biology

Topical Carvedilol Delivery Prevents Uv-Induced Skin Cancer With Negligible Systemic Absorption. International Journal of Pharmaceutics (2021)

Md Abdullah ShamimSteven YeungAyaz ShahidMengbing ChenJeffrey WangPreshita DesaiCyrus ParsaRobert OrlandoFrank L. Meyskens JrKristen M. KellyBradley T. AndresenYing Huang

dermatologymedicinepharmacologynanomedicinetopical carvedilol deliverypharmaceutical sciencesuv-induced skin cancerskin cancerdrug deliverypharmaceutics

1
2
3
4
5
39
10 / page

Frank L. Meyskens

Professor

University of California, Irvine

Affiliations

School of Medicine

Biological Chemistry

Frank L. Meyskens is currently serving as a Biological Chemistry Professor at University of California, Irvine.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Frank L. Meyskens

University of California, Irvine

Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Data From Back to the Future: Mechanism-Based, Mutation-Specific Combination Chemoprevention With a Synthetic Lethality Approach. (2023)

Frank L. MeyskensEugene W. Gerner

pharmacologymutation-specific combination chemopreventiongeneticsmedicinal chemistry

Data From Regulatory Approval of Cancer Risk-Reducing (Chemopreventive) Drugs: Moving What We Have Learned Into the Clinic. (2023)

Frank L. MeyskensGregory A. CurtDean E. BrennerGary GordonRonald B. HerbermanOlivera FinnGary J. KelloffSamir N. KhleifCaroline C. SigmanEva Szabo

medicinepharmacologycancer risk-reducingresearch policydrug policyoncologycancer riskcancer preventionhealth policy

Data From Topically Applied Carvedilol Attenuates Solar Ultraviolet Radiation Induced Skin Carcinogenesis. (2023)

Kevin M. HuangSherry LiangSteven YeungEtuajie OiyemhonlanKristan H. ClevelandCyrus ParsaRobert OrlandoFrank L. MeyskensBradley T. AndresenYing Huang

carcinogenesisdermatologyradiation oncologyskin carcinogenesiscutaneous biologyskin cancersolar ultraviolet radiation

Recent Advances in Clinical Research for Skin Cancer Chemoprevention. Cancers (2023)

Ruby TowSamuel HanounBradley AndresenAyaz ShahidJeffrey WangKristen M. KellyFrank L. MeyskensYing Huang

dermatologycancer careradiation oncologyepidemiologycancer researchclinical researchoncologyskin cancer chemopreventioncancer treatmentskin cancercancer prevention

Supplementary Figure Legends From Topically Applied Carvedilol Attenuates Solar Ultraviolet Radiation Induced Skin Carcinogenesis. (2023)

Kevin M. HuangSherry LiangSteven YeungEtuajie OiyemhonlanKristan H. ClevelandCyrus ParsaRobert OrlandoFrank L. MeyskensBradley T. AndresenYing Huang

carcinogenesisdermatologyradiation oncologyradiation biologyoral cancerskin carcinogenesisskin cancercutaneous biologypathologytumor biologysolar ultraviolet radiation

Transfersome Encapsulated With the R-Carvedilol Enantiomer for Skin Cancer Chemoprevention. Nanomaterials (2023)

Md Abdullah ShamimAyaz ShahidPabitra K. SardarSteven YeungJeremiah ReyesJenny KimCyrus ParsaRobert OrlandoJeffrey WangKristen M. KellyFrank L. MeyskensBradley T. AndresenYing Huang

nanobiotechnologymaterials sciencedermatologynanomedicinebiomedical engineeringskin cancer chemopreventionnanomaterialstherapeutic nanomaterialsr-carvedilol enantiomerdrug deliverynanotechnology

Replace the Advance Directive With a Patient Activation Approach to Serious Illness Communication. Journal of the American Geriatrics Society (2022)

Mark Allen O'RourkeJamie S. MyersFrank L. Meyskens

advance directivehealth communicationcritical caregeriatric medicinegeriatricsserious illness communication

Miracles. Encyclopedia of the Bible Online (2021)

The Ionophore Thiomaltol Induces Rapid Lysosomal Accumulation of Copper and Apoptosis in Melanoma. Metallomics (2021)

Ottis ScrivnerLong DaoM Karen Newell-RogersBabbak ShahandehFrank L MeyskensSusan Kurumi KozawaFeng Liu-SmithGermán Plascencia-VillaMiguel José-YacamánShang JiaChristopher J ChangPatrick J Farmer

Topical Carvedilol Delivery Prevents Uv-Induced Skin Cancer With Negligible Systemic Absorption. International Journal of Pharmaceutics (2021)

Md Abdullah ShamimSteven YeungAyaz ShahidMengbing ChenJeffrey WangPreshita DesaiCyrus ParsaRobert OrlandoFrank L. Meyskens JrKristen M. KellyBradley T. AndresenYing Huang

dermatologymedicinepharmacologynanomedicinetopical carvedilol deliverypharmaceutical sciencesuv-induced skin cancerskin cancerdrug deliverypharmaceutics

1
2
3
4
5
39
10 / page

Similar Faculty Members

Steven M. Dubinett

Institution

University of California, Los Angeles

oncology

cancer research

Peter J. O'Dwyer

Institution

University of Pennsylvania

oncology

pharmacology

Mary Kay Washington, Ph.D., M.D

Institution

Vanderbilt University

immunology

gastrointestinal oncology

Stephen D. Hursting

Institution

University of North Carolina at Chapel Hill

health science

energy balance

Kazuaki Takabe

Institution

University at Buffalo

hepatology

pathology

Janice Mehnert

Institution

New York University

tumor targeting

radiation oncology

David S. Alberts, M.D

Institution

University of Arizona

chemoprevention strategies

cancer prevention

Robert J. Coffey, M.D

Institution

Vanderbilt University

gi neoplasia

oncogene

Ralph R. Weichselbaum

Institution

University of Chicago

oncology

radiation oncology

Shantu Amin

Institution

Pennsylvania State University

cancer letter

polycyclic aromatic hydrocarbon

Similar Faculty Members

Steven M. Dubinett

Institution

University of California, Los Angeles

oncology

cancer research

Peter J. O'Dwyer

Institution

University of Pennsylvania

oncology

pharmacology

Mary Kay Washington, Ph.D., M.D

Institution

Vanderbilt University

immunology

gastrointestinal oncology

Stephen D. Hursting

Institution

University of North Carolina at Chapel Hill

health science

energy balance

Kazuaki Takabe

Institution

University at Buffalo

hepatology

pathology

Janice Mehnert

Institution

New York University

tumor targeting

radiation oncology

David S. Alberts, M.D

Institution

University of Arizona

chemoprevention strategies

cancer prevention

Robert J. Coffey, M.D

Institution

Vanderbilt University

gi neoplasia

oncogene

Ralph R. Weichselbaum

Institution

University of Chicago

oncology

radiation oncology

Shantu Amin

Institution

Pennsylvania State University

cancer letter

polycyclic aromatic hydrocarbon